although the in vitro antibacterial activity of clindamycin and pirlimycin are nearly identical , the latter compound is 2-20 times more active than clindamycin when administered to mice experimentally infected with strains of staphylococcus aureus , streptococcus pyogenes , streptococcus pneumoniae , bacteroides fragilis , and plasmodium berghei .
C0279516
antibacterial
C0008947
clindamycin